title: Single daily dose ceftriaxone therapy in epiglottitis.
abstract: Ceftriaxone as a single daily intravenous dose for 5 days was used to treat seven patients with proven Haemophilus influenzae epiglottitis. All children responded favourably. The serum levels achieved exceeded the MIC by up to 1500 times at the trough level during and for up to 24 h after the completion of the treatment. Side effects were mild and transient and did not disrupt the continuity of the treatment. Ceftriaxone potentially offers a number of clinical and economic advantages in the management of epiglottitis.
authors.affiliation: Mater Children's Hospital, South Brisbane, Queensland, Australia.
authors.forename: G J
authors.initials: GJ
authors.lastname: Knight
authors.forename: M A
authors.initials: MA
authors.lastname: Harris
authors.forename: M
authors.initials: M
authors.lastname: Parbari
authors.forename: M J
authors.initials: MJ
authors.lastname: O'Callaghan
authors.forename: I B
authors.initials: IB
authors.lastname: Masters
mesh_terms: D002443:Ceftriaxone / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D002675:Child, Preschool; D003967:Diarrhea / Q000139:chemically induced; D004826:Epiglottitis / Q000188:drug therapy* / Q000382:microbiology; D006192:Haemophilus Infections; D006193:Haemophilus influenzae; D006801:Humans; D007223:Infant; D007275:Injections, Intravenous
chemical_list: D002443:Ceftriaxone